| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 570,7 k € | +14.3% | 499,1 k € | -16.0% | 594,2 k € | |||||||||||||||
| Gross margin | 528,5 k € | -10.8% | 592,4 k € | +22.5% | 483,6 k € | +26.0% | 383,8 k € | -29.3% | 542,6 k € | +18.0% | 460,0 k € | -12.2% | 524,0 k € | +9.5% | 478,4 k € | +3.0% | 464,7 k € | +3.2% | 450,1 k € | +45.8% | 308,7 k € | +0.7% | 306,7 k € | +4.8% | 292,7 k € | -8.9% | 321,2 k € | -20.9% | 406,3 k € | +18.8% | 342,0 k € | +2.4% | 334,0 k € | |
| EBITDA | 525,6 k € | -10.9% | 589,8 k € | +22.6% | 481,1 k € | +25.8% | 382,5 k € | -29.3% | 541,2 k € | +18.0% | 458,6 k € | -12.3% | 522,7 k € | +9.6% | 476,9 k € | +2.8% | 463,7 k € | +3.3% | 448,8 k € | +46.0% | 307,3 k € | +0.6% | 305,4 k € | +4.8% | 291,5 k € | -8.9% | 320,0 k € | -21.2% | 405,8 k € | +18.8% | 341,6 k € | +2.5% | 333,3 k € | |
| Operating profit | 511,7 k € | -11.1% | 575,8 k € | +23.3% | 467,2 k € | +26.8% | 368,5 k € | -30.1% | 527,2 k € | +18.6% | 444,5 k € | -12.0% | 505,2 k € | +10.0% | 459,5 k € | +3.0% | 446,1 k € | +2.6% | 434,6 k € | +48.4% | 293,0 k € | +0.5% | 291,4 k € | +5.0% | 277,5 k € | -9.2% | 305,6 k € | -21.7% | 390,6 k € | +19.7% | 326,3 k € | +1.3% | 322,2 k € | |
| Profit/loss | 445,0 k € | +8.6% | 409,9 k € | +14.0% | 359,7 k € | +48.8% | 241,8 k € | -34.6% | 369,6 k € | +25.4% | 294,8 k € | -12.5% | 336,9 k € | +28.7% | 261,8 k € | -11.4% | 295,5 k € | +7.4% | 275,1 k € | +70.7% | 161,1 k € | -11.2% | 181,4 k € | +2.1% | 177,6 k € | -12.1% | 201,9 k € | -24.1% | 266,1 k € | +20.6% | 220,7 k € | +3.7% | 212,8 k € | |
| Equity | 2,4 M € | +4.8% | 2,2 M € | +7.1% | 2,1 M € | +15.4% | 1,8 M € | -10.4% | 2,0 M € | -7.9% | 2,2 M € | +15.4% | 1,9 M € | +21.4% | 1,6 M € | -5.5% | 1,7 M € | +21.6% | 1,4 M € | +25.1% | 1,1 M € | +17.3% | 933,4 k € | +87.4% | 498,1 k € | -17.3% | 602,7 k € | +50.4% | 400,7 k € | -25.0% | 534,6 k € | +62.5% | 329,0 k € | |
| Total assets | 2,4 M € | +4.6% | 2,3 M € | -3.9% | 2,4 M € | +15.2% | 2,1 M € | -9.9% | 2,3 M € | -7.2% | 2,5 M € | +12.4% | 2,2 M € | +18.5% | 1,9 M € | -5.4% | 2,0 M € | +19.5% | 1,7 M € | +19.7% | 1,4 M € | +14.2% | 1,2 M € | +13.0% | 1,1 M € | +18.3% | 914,6 k € | +18.8% | 769,8 k € | +13.7% | 676,8 k € | +66.9% | 405,6 k € | |
| Cash | 103,8 k € | +90.4% | 54,5 k € | -53.5% | 117,3 k € | -72.0% | 418,4 k € | +81.6% | 230,3 k € | +56.0% | 147,7 k € | -41.1% | 250,7 k € | +3874.1% | 6,3 k € | -93.8% | 102,0 k € | +1397.8% | 6,8 k € | -91.2% | 77,3 k € | -24.6% | 102,4 k € | -48.1% | 197,2 k € | -54.6% | 434,4 k € | +80.5% | 240,6 k € | +37.4% | 175,1 k € | +677.1% | 22,5 k € | |
| Debts | 80,3 k € | -3.2% | 83,0 k € | -74.5% | 325,2 k € | +14.4% | 284,4 k € | -6.5% | 304,1 k € | -1.6% | 309,1 k € | -5.1% | 325,9 k € | +3.8% | 314,0 k € | -4.7% | 329,4 k € | +10.0% | 299,5 k € | -0.2% | 300,2 k € | +4.1% | 288,4 k € | -50.6% | 583,4 k € | +87.1% | 311,9 k € | -15.3% | 368,3 k € | +159.0% | 142,2 k € | +85.6% | 76,6 k € | |
| Staff | — | — | 0 | 0 | — | — | — | — | — | — | — | — | — | — | — | — | — | |||||||||||||||||
Private limited company · Sint-Pieters-Leeuw · incorporated on 09/10/2008
Private limited company profitable and well capitalised. Cash position rising (+90.4%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Dr. Hendrik DE RAEVE is a Private limited company incorporated in 2008. Its main activity is: Other human health activities. Its registered office is in Sint-Pieters-Leeuw.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette